Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Dr.Mai Mohamed Elhassan Mustafa Assistant Professor
Lower Respiratory Tract Infections
objectives
By the end of this lecture each student should be able to;
¨ Diagnose and manage Acute Bronchiolitis ¨ Diagnose and manage pneumonia and relate the
age to the suspected organism.
Definition
¨ Lower respiratory tract infections is a term used to describe any infection below the vocal cords.
include : ¨ Pneumonia ¨ Bronchitis ¨ Bronchiolitis ¨ Laryngotracheobronchitis (croup)
Definition
-Acute infectious inflammation of the bronchioles resulting in wheezing and airways obstruction in children less than 2 y e a r s o l d .
-It is caused by Respiratory Syncytial V i r u s R S V
PATHOGENESIS
§ Bronchiolar cell necrosis, ciliary
disruption, peribronchial lymphocytic infiltration
§ Edema, excessive mucus, sloughed epithelium lead to airway obstruction & atelectasis
CLINICAL FEATURES/symptoms
§ Begin with upper respiratory tract symptoms: nasal congestion, rhino rhea, mild cough, low-grade fever.
Progress in 3-6 days to : § rapid respirations, § chest retractions § wheezing.
CLINICAL FEATURES/signs
§ Tachypnea +/_ signs of respiratory distress § Rhonchi, wheezes +/- crackles. § Possible dehydration § Possible conjunctivitis or otitis media § Possible cyanosis or apnea
RISK FACTORS for SEVERITY
Ø Prematurity Ø Low birth weight Ø Age less than 12
weeks Ø Chronic pulmonary
disease
Ø Neurologic disease Ø Anatomical defects of
the airways Ø significant cardiac
disease Ø Immunodeficiency
DIFFERENTIAL DIAGNOSIS § Asthma § Bronchitis § pneumonia § Chronic lung disease § Aspiration pneumonia § Congenital heart disease or heart failure
DIAGNOSIS
§ Clinical diagnosis based on history and physical examination.
§ WBC count normal § Supported by CXR findings: hyperinflation
COURCE
§ Usually self-limiting. Indication for hospitalization § Children with severe disease. § Toxic with poor feeding, lethargy, dehydration. § Apnea § Hypoxemia § Parent unable to care for child at home.
TREATMENT
Ø Ist 48_96hr higher risk for repiratory compromised
Out lines of treatment: Ø Supportive care
Ø Frequent monitoring - HR, RR and oxygen saturation . Ø Arterial Blood gases if in ICU or has severe distress.
TREATMENT
Ø Supportive treatment Ø Oxygen to maintain saturations > 92% Ø IV fluids –if dehydrated or less feeding. Ø Antipyretics---if febrile. Ø Mechanical ventilation---if indicated. Ø CORTICOSTERIODS- Not recommended may be
helpful in children with chronic lung disease.
TREATMENT
Ø RIBAVIRINMay be useful in infants with confirmed RSV at risk for more severe disease.
Ø ANTIBIOTICS - Not useful
Prevention --PALIVIZUMAB Monoclonal antibody against RSV indicated in infants less than 2years with;
1. Prematurity 2. Chronic lung disease 3. Congenital heart disease
COMPLICATIONS
¨ Apnea ¨ Respiratory failure ¨ secondary bacterial infection
§ Case fatality rate less than 1%.
§ Higher morbidity and mortality in infants with
CHD ,immunodeficiency and bronchopulmonary dysplasia.
Pneumonia
¨ Inflammation of lung parenchyma CAUSES
¨ Infectious ; microorganisms ¨ Noninfectious causes:
¤ Aspiration of food or gastric acid ¤ Foreign bodies ¤ Hydrocarbons, and lipoid substances ¤ Hypersensitivity reactions ¤ Drug- or radiation-induced pneumonitis
Epidemiology
¨ Significant cause of mortality in children < 5years age .
¨ ~4 million deaths worldwide/year* ¨ Reduction after introduction of congugate
pneumococcal and Hib vaccine.
Etiology
¨ Bacterial pneumonia
¨ Viral pneumonia ¤ Predominant cause in infants and children younger than 5 yr
of age ¤ Peak attack rate for viral pneumonia is between the ages of
2 and 3 yr ¤ Influenza and RSV, especially in children younger than 3 yr
of age ¤ others, Para influenza viruses, rhinoviruses , and
adenoviruses.
RISK FACTORS
¨ Specific risk factors:
¤ Lung disease ( cystic fibrosis)
¤ Anatomic problems (tracheoesophageal fistula)
¤ Gastro esophageal reflux with aspiration
¤ Neurologic disorders with decreased protection of the
airway or compromised clearing of the airway
¤ Altered immune system
Classification
Recent 1.Community-acquired pneumonia (CAP) is infectious pneumonia in a person who has not
recently been hospitalized. CAP is the most common type of pneumonia. The most common causes of CAP vary depending on a
person's age, 2.Hospital-acquired pneumonia ¨ Also called nosocomial pneumonia,
Causes of Community-Acquired Pneumonia by Age Group
Age Common causes
Less than one Month bacterial Group B streptococci Escherichia coli
S. pneumoniae
1 month to 3 months Viruses, bacterial • S. pneumoniae , H. influenzae type B • Chlamydia trachomatis,M. pneumoniae,
3 months to12 months
Viruses,
bacterial ( S. pneumoniae ,H. influenzae type B) Chlamydia trachomatis, M. pneumoniae, Group A streptococus
2 to 5 years Viruses,
bacterial S. pneumoniae , H. influenzae type B Chlamydia trachomatis,M. pneumoniae, s. aureus,Group A streptococus
5 to 18 years M. pneumoniae, S. pneumoniae, C. pneumoniae H. influenzae type B. and viruses
Pathogenesis
¨ Viral pneumonia ¤ From spread of infection along the airways ¤ Direct injury of the respiratory epithelium ¤ Results:
n Airway obstruction from swelling n Abnormal secretions n Cellular debris n Significant hypoxemia
¤ Predisposed to secondary bacterial infection
Pathogenesis
q Bacterial pneumonia
-Pathology varies according to organism
q Mycoplasma. pneumonia
n Attaches to the respiratory epithelium
n Inhibits ciliary action
n Leads to cellular destruction
Pathogenesis
¨ Bacterial Infections ¤ S. pneumoniae
n Edema that aids in the proliferation of organisms and spread into adjacent portions of lung
n Resulting in the characteristic focal lobar involvement
¤ Group A Streptococcus n More diffuse infection with interstitial pneumonia n Necrosis of tracheobronchial mucosa n Large amounts of exudate, edema, and hemorrhage n Involvement of lymphatic vessels n Increased likelihood of pleural involvement
Pathogenesis
¨ S. aureus pneumonia
¤ Often unilateral
¤ Extensive areas of hemorrhagic necrosis
¤ Irregular areas of cavitation of the parenchyma
n Pneumatoceles
n Empyema
n Bronchopulmonary fistulas.
Clinical Manifestations
¨ Most often preceded by URTI (rhinitis and cough) ¨ Fever - lower in viral pneumonia ¨ Tachypnea (constant sign) ¨ Increased work of breathing. ¨ Signs of severe infection (cyanosis , respiratory
fatigue, especially in infants) ¤ Crackles and wheezing ¤ Signs of consolidation
Clinical Manifestations
¨ Bacterial pneumonia in older children
¤ Brief upper respiratory tract illness
¤ Followed by the abrupt onset of chills and high fever
¤ Drowsiness with intermittent periods of restlessness
¤ Rapid respirations
¤ Cough
¤ Chest pain
¤ Anxiety
Clinical Manifestations
¨ Physical findings depend on the stage of pneumonia ¤ Early in the course:
n Diminished breath sounds n Scattered crackles, and rhonchi
¤ Increasing consolidation n Dullness on percussion is noted n Breath sounds are markedly diminished n Abdominal distention - swallowed air or ileus n Liver may seem enlarged n Nuchal rigidity, in the absence of meningitis - right upper Lobe involvement.
Clinical presentation
¨ Some infants with bacterial pneumonia may have associated vomiting, anorexia and abdominal distention
Diagnosis
¨ Depends on history &physical examination. ¨ Definitive diagnosis based on viral and bacterial
cultures Ø Viral: isolated from secretions
Ø Bacterial: Pleural fluid, Blood (10-30% positive, pneumococcal)
Ø ASO titers – group A strep
Ø Mycoplasma – cold agglutins (non-specific)
Diagnosis
¨ White blood cell (WBC) count can be helpful ¤ Viral: decreased, normal or elevated
n Usually not higher than 20,000/mm3 n Lymphocyte predominance n Adenovirus, may not follow this pattern
¤ Bacterial: elevated WBC count n 15,000–40,000/mm3 n Predominance of granulocytes
Diagnosis
¨ Chest radiograph confirms the diagnosis and detect complication e.g. pleural effusion and empyema.
¨ In general, viral pneumonia: ¤ Hyperinflation with bilateral interstitial infiltrates
¨ Lobar consolidation is typically seen with pneumococcal pneumonia
¨ Radiographic appearance alone is not diagnostic and other clinical features must be considered
Upper lobar
¨ R. middle lobe ¨ Bronchopneumonia
Pneumonia----indication for admission
¨ Age < 6 month ¨ Sickle cell anemia with acute chest syndrome ¨ Toxic appearance ¨ Vomiting, dehydration ¨ Toxic appearance ¨ Immunocompromised state ¨ Multiple lobe involvement ¨ Requirements of supplemental oxygen ¨ No response to appropriate oral antibiotics
Treatment—bacterial pneumonia
Antibiotics Specific treatment depends on causative organism and clinical
appearance ,If mildly ill Out patient; § preschool age -------- oral amoxicillin
§ School age (atypical)------------ macrolid (azithromycin)
§ Adolescent ---------- flurorquinolone
Hospitalized cases
Approach based on the clinical manifestation at
presentation:
If suspected bacterial pneumonia parenteral antibiotics
(cephalosporins)
-If diagnosis suggest staphylococcal pneumonia add
vancomycin or clindamycin
Complications
¤ Pleural effusion ¤ Empyema ¤ Pericarditis
¨ Bacteremia and hematologic spread ¨ Rare complications of pneumococcal and H.Influenzae
type b infection ¤ Meningitis ¤ Suppurative arthritis ¤ Osteomyelitis
Recurrent Pneumonias? q Defined as two or more episode in a single year or
three or more episode ever with radiographic clearing in between.
causes § Disorders of Immunity § Anatomical disorders. § Foreign Body
THANKS